United States · Series B startup

Who invested in Acuity Pharmaceuticals

One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$15Mraised across 1 round since 2004, from 1 source

Latest round
Series B, $15MOct 2004
Investors
6
See who backed them

The rounds

  1. Oct 2004

Founders and team

From Acuity Pharmaceuticals's own website: 8 on the team.

  • Adam LogalSenior Vice President and Chief Financial Officer
  • Phil FrostChief Executive Officer and Chairman
  • Steve RubinExecutive Vice President, Administration and Director
  • Elias A. Zerhouni M.D.President and Vice Chairman
  • Gary J. NabelChief Innovation Officer and Director
  • Jane HsiaoChief Technical Officer and Vice Chairman
  • Gene YauHead of Business Development
  • John A. PaganelliDirector

The exit

ExitBuyerPriceWhen
AcquiredOPKO HealthundisclosedJun 2011

From historical deal records. Wrong? Tell us.

Everyone who backed them

BioAdvanceVC firm1round
Psilos GroupPrivate equity1round
Diamond Capital CompanyGrowth equity1round
Och-Ziff Capital ManagementInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Acuity Pharmaceuticals

Who invested in Acuity Pharmaceuticals?

Acuity Pharmaceuticals's investors include Ben Franklin Technology Partners, Johnson & Johnson Development Corporation (JJDC), BioAdvance, Psilos Group and Diamond Capital Company, and 1 more on record.

How much has Acuity Pharmaceuticals raised?

Acuity Pharmaceuticals has raised $15M across 1 round since 2004.

When did Acuity Pharmaceuticals last raise?

Acuity Pharmaceuticals's most recent round was a Series B of $15M in Oct 2004.

What was Acuity Pharmaceuticals's biggest round?

Its most recent round, $15M in Oct 2004, is also its largest on record.

Who backed Acuity Pharmaceuticals first?

Acuity Pharmaceuticals's first round on record, in Oct 2004, was backed by Ben Franklin Technology Partners, Johnson & Johnson Development Corporation (JJDC) and BioAdvance and 3 others.

What stage is Acuity Pharmaceuticals at?

Acuity Pharmaceuticals's latest named round is a Series B, in Oct 2004.

Where is Acuity Pharmaceuticals based?

Acuity Pharmaceuticals is based in the United States.

Companies like Acuity Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.